All November 2024 Articles

From 2024-11-01 to 2024-11-30

ImageTitlepost_modified
ProfessionalPancreatic Cancer Awareness MonthPancreatic Cancer Awareness MonthNov 06, 20242024-11-06
CPDsUpdate on the prevention and management of RSV in IrelandUpdate on the prevention and management of RSV in IrelandNov 06, 20242024-11-06
ProfessionalThe impact of the Windsor Framework on FMD in IrelandThe impact of the Windsor Framework on FMD in IrelandNov 08, 20242024-11-06
General Election 2024General Election 2024Nov 08, 20242024-11-06
Economic update for pharmacy sectorEconomic update for pharmacy sectorNov 06, 20242024-11-06
ProfessionalEuropean Antibiotic Awareness DayEuropean Antibiotic Awareness DayNov 14, 20242024-11-06
EditorialPolitical stunts and inward groansPolitical stunts and inward groansNov 06, 20242024-11-06
CPDsRespiratory tract infections and antimicrobial stewardshipRespiratory tract infections and antimicrobial stewardshipNov 14, 20242024-11-05
Pharmacy governance roles: Non-pharmacist ownerPharmacy governance roles: Non-pharmacist ownerNov 21, 20242024-11-05
PCRS Annual Report 2023PCRS Annual Report 2023Nov 21, 20242024-11-05
PoliticsPharmacy Show 2024Pharmacy Show 2024Nov 05, 20242024-11-05
PoliticsPharmacy fees on the political agenda as election loomsPharmacy fees on the political agenda as election loomsNov 05, 20242024-11-05
PSI Council report: 3 October 2024PSI Council report: 3 October 2024Nov 05, 20242024-11-05
OtherFinding meaning at work: the secret to job satisfactionFinding meaning at work: the secret to job satisfactionNov 05, 20242024-11-05
Original Pack DispensingOriginal Pack DispensingNov 05, 20242024-11-05
ContractsCommunity Drug Schemes:  Streamlining pharmacy claiming and reimbursement processCommunity Drug Schemes: Streamlining pharmacy claiming and reimbursement processOct 14, 20242024-10-14
NIS2: New cybersecurity obligations for larger pharmaciesNIS2: New cybersecurity obligations for larger pharmaciesOct 07, 20242024-10-07
Astellas Initiates Phase 3 Clinical Study of Fezolinetant for VMS in women with breast cancer receiving adjuvant endocrine therapyAstellas Initiates Phase 3 Clinical Study of Fezolinetant for VMS in women with breast cancer receiving adjuvant endocrine therapyOct 07, 20242024-10-07
European Commission approves Astellas’ PADCEV (enfortumab vedotin) in combination with KEYTRUDA (pembrolizumab) for first-line treatment of advanced urothelial cancerEuropean Commission approves Astellas’ PADCEV (enfortumab vedotin) in combination with KEYTRUDA (pembrolizumab) for first-line treatment of advanced urothelial cancerOct 07, 20242024-10-07
ProfessionalStrengthening cybersecurity in Irish pharmacies: a key priority for OctoberStrengthening cybersecurity in Irish pharmacies: a key priority for OctoberOct 07, 20242024-10-07
Medication safety: my perspective as both a pharmacist and a patientMedication safety: my perspective as both a pharmacist and a patientOct 07, 20242024-10-07
ProfessionalManaging winter illness and antimicrobial resistanceManaging winter illness and antimicrobial resistanceOct 07, 20242024-10-07
ProfessionalAutumn/Winter Vaccination Programme updateAutumn/Winter Vaccination Programme updateOct 07, 20242024-10-07
Pharmacy Governance Roles: Superintendent PharmacistPharmacy Governance Roles: Superintendent PharmacistOct 07, 20242024-10-07
STADA survey of patients’ opinions on healthcareSTADA survey of patients’ opinions on healthcareOct 07, 20242024-10-07
OtherIPU Jobs: Connecting Ireland’s pharmacies with top talent and opportunitiesIPU Jobs: Connecting Ireland’s pharmacies with top talent and opportunitiesOct 17, 20242024-10-07
Dispensing change: Lobbying tips for community pharmacistsDispensing change: Lobbying tips for community pharmacistsOct 07, 20242024-10-07
ImageTitlepost_modified
ProfessionalPancreatic Cancer Awareness MonthPancreatic Cancer Awareness MonthNov 06, 20242024-11-06
CPDsUpdate on the prevention and management of RSV in IrelandUpdate on the prevention and management of RSV in IrelandNov 06, 20242024-11-06
ProfessionalThe impact of the Windsor Framework on FMD in IrelandThe impact of the Windsor Framework on FMD in IrelandNov 08, 20242024-11-06
General Election 2024General Election 2024Nov 08, 20242024-11-06
Economic update for pharmacy sectorEconomic update for pharmacy sectorNov 06, 20242024-11-06
ProfessionalEuropean Antibiotic Awareness DayEuropean Antibiotic Awareness DayNov 14, 20242024-11-06
EditorialPolitical stunts and inward groansPolitical stunts and inward groansNov 06, 20242024-11-06
CPDsRespiratory tract infections and antimicrobial stewardshipRespiratory tract infections and antimicrobial stewardshipNov 14, 20242024-11-05
Pharmacy governance roles: Non-pharmacist ownerPharmacy governance roles: Non-pharmacist ownerNov 21, 20242024-11-05
PCRS Annual Report 2023PCRS Annual Report 2023Nov 21, 20242024-11-05
PoliticsPharmacy Show 2024Pharmacy Show 2024Nov 05, 20242024-11-05
PoliticsPharmacy fees on the political agenda as election loomsPharmacy fees on the political agenda as election loomsNov 05, 20242024-11-05
PSI Council report: 3 October 2024PSI Council report: 3 October 2024Nov 05, 20242024-11-05
OtherFinding meaning at work: the secret to job satisfactionFinding meaning at work: the secret to job satisfactionNov 05, 20242024-11-05
Original Pack DispensingOriginal Pack DispensingNov 05, 20242024-11-05
ContractsCommunity Drug Schemes:  Streamlining pharmacy claiming and reimbursement processCommunity Drug Schemes: Streamlining pharmacy claiming and reimbursement processOct 14, 20242024-10-14
NIS2: New cybersecurity obligations for larger pharmaciesNIS2: New cybersecurity obligations for larger pharmaciesOct 07, 20242024-10-07
Astellas Initiates Phase 3 Clinical Study of Fezolinetant for VMS in women with breast cancer receiving adjuvant endocrine therapyAstellas Initiates Phase 3 Clinical Study of Fezolinetant for VMS in women with breast cancer receiving adjuvant endocrine therapyOct 07, 20242024-10-07
European Commission approves Astellas’ PADCEV (enfortumab vedotin) in combination with KEYTRUDA (pembrolizumab) for first-line treatment of advanced urothelial cancerEuropean Commission approves Astellas’ PADCEV (enfortumab vedotin) in combination with KEYTRUDA (pembrolizumab) for first-line treatment of advanced urothelial cancerOct 07, 20242024-10-07
ProfessionalStrengthening cybersecurity in Irish pharmacies: a key priority for OctoberStrengthening cybersecurity in Irish pharmacies: a key priority for OctoberOct 07, 20242024-10-07
Medication safety: my perspective as both a pharmacist and a patientMedication safety: my perspective as both a pharmacist and a patientOct 07, 20242024-10-07
ProfessionalManaging winter illness and antimicrobial resistanceManaging winter illness and antimicrobial resistanceOct 07, 20242024-10-07
ProfessionalAutumn/Winter Vaccination Programme updateAutumn/Winter Vaccination Programme updateOct 07, 20242024-10-07
Pharmacy Governance Roles: Superintendent PharmacistPharmacy Governance Roles: Superintendent PharmacistOct 07, 20242024-10-07
STADA survey of patients’ opinions on healthcareSTADA survey of patients’ opinions on healthcareOct 07, 20242024-10-07
OtherIPU Jobs: Connecting Ireland’s pharmacies with top talent and opportunitiesIPU Jobs: Connecting Ireland’s pharmacies with top talent and opportunitiesOct 17, 20242024-10-07
Dispensing change: Lobbying tips for community pharmacistsDispensing change: Lobbying tips for community pharmacistsOct 07, 20242024-10-07

We are looking for contributors

IPU Review

The IPU Review is addressed to Healthcare Professionals

Are you a Healthcare professional?

IPU

Members Login